Wiktoria Podlasiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wiktoria Podlasiewicz has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Skoczylas
Uniwersytet Opolski
7 shared publications - Anna Nowak
University Clinical Hospital in Opole, Poland
7 shared publications - Jakub Kurasz
University of Opole, Institute of Medical Sciences Student Research Group in Otorhinolaryngology Opole Poland
7 shared publications - Katarzyna Pala
Uniwersytet Opolski
7 shared publications - Maria Golińska
University Clinical Hospital in Opole, Poland
7 shared publications - Mateusz Łyko
University of Opole
7 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
IMPACT OF PHARMACOLOGICAL TREATMENT OF CHRONIC VENOUS DISEASE ON PATIENTS' QUALITY OF LIFE AND SOCIAL FUNCTIONING
Aim: The aim of this study was to review the literature on the efficacy of phlebotonics in the treatment of chronic venous disease (CVD) of the lower limbs, with particular emphasis on their impact on patients' quality of life, social functioning and daily activity. Materials and Methods: A narrative literature review was conducted in PubMed/MEDLINE, Cochrane Library, Google Scholar and ScienceDirect, covering publications from 1992 to 2026. A total of 22 references were included – randomised controlled trials, systematic reviews, meta-analyses and review articles. Results: Chronic venous disease significantly impairs patients' quality of life in both physical and psychosocial dimensions. Phlebotonics act primarily symptomatically, reducing pain, oedema and limb heaviness, which translates into improved daily functioning and social activity. Micronized purified flavonoid fraction (MPFF) has the best-documented efficacy in symptom reduction and quality of life improvement, assessed with the CIVIQ-20 questionnaire, with the highest level of evidence according to GRADE. Results of available studies are inconclusive and depend on the type of phlebotonic used and measurement tools applied. Conclusions: Phlebotonics should not be treated as a homogeneous therapeutic class, as individual substances differ in efficacy profile and mechanism of action. Effective pharmacological management of CVD contributes to improved social functioning and health-related quality of life. Further clinical studies with longer observation periods and standardised quality of life tools are needed to better understand the full impact of these drugs on patients' everyday lives.
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessIMPACT OF PHARMACOLOGICAL TREATMENT OF CHRONIC VENOUS DISEASE ON PATIENTS' QUALITY OF LIFE AND SOCIAL FUNCTIONING
Aim: The aim of this study was to review the literature on the efficacy of phlebotonics in the treatment of chronic venous disease (CVD) of the lower limbs, with particular emphasis on their impact on patients' quality of life, social functioning and daily activity. Materials and Methods: A narrative literature review was conducted in PubMed/MEDLINE, Cochrane Library, Google Scholar and ScienceDirect, covering publications from 1992 to 2026. A total of 22 references were included – randomised controlled trials, systematic reviews, meta-analyses and review articles. Results: Chronic venous disease significantly impairs patients' quality of life in both physical and psychosocial dimensions. Phlebotonics act primarily symptomatically, reducing pain, oedema and limb heaviness, which translates into improved daily functioning and social activity. Micronized purified flavonoid fraction (MPFF) has the best-documented efficacy in symptom reduction and quality of life improvement, assessed with the CIVIQ-20 questionnaire, with the highest level of evidence according to GRADE. Results of available studies are inconclusive and depend on the type of phlebotonic used and measurement tools applied. Conclusions: Phlebotonics should not be treated as a homogeneous therapeutic class, as individual substances differ in efficacy profile and mechanism of action. Effective pharmacological management of CVD contributes to improved social functioning and health-related quality of life. Further clinical studies with longer observation periods and standardised quality of life tools are needed to better understand the full impact of these drugs on patients' everyday lives.
- Open Access
- 18 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 74, 75172
The K-Hole Collapse: A Systematic Review of Multi-Organ Somatotoxicity and Management Strategies in Chronic Ketamine Misuse
Ketamine is a psychoactive substance and an N-methyl-D-aspartate (NMDA) receptor antagonist, commonly used in anesthesiology, psychiatry, and emergency medicine. Its unique dissociative properties have led to a significant global increase in recreational misuse, particularly among young adults in nightlife environments. While the medical applications of ketamine demonstrate a favorable safety profile, its uncontrolled, chronic consumption poses severe toxicological risks. The primary mechanism of action of ketamine relies on blocking NMDA receptors, which leads to a secondary glutamate surge and localized neurotoxicity. This study aims to systematically evaluate the multi-organ manifestations, clinical complications, and management strategies associated with ketamine misuse. The article was developed using the "PubMed" and "Google Scholar" databases, with a particular emphasis on articles published after 2021. Chronic recreational ketamine misuse induces severe somatotoxic and neuropsychiatric injuries, including permanent cognitive and executive deficits, ketamine-induced uropathy (KIU) with secondary hydronephrosis, and excruciating gastrointestinal episodes ("ketamine cramps") triggered by sphincter of Oddi dyskinesia. Recent reports also highlight significant structural cardiac remodeling, myocardial fibrosis, and the risk of hypercapnic respiratory failure during acute, high-dose intoxications. Multidisciplinary treatment requires absolute abstinence as the cornerstone of therapy, combined with targeted pharmacotherapy, symptomatic clinical stabilization, and psychotherapy. Due to a therapeutic gap resulting from the lack of established pharmacological treatments to reduce ketamine cravings, further clinical trials are essential to improve patient recovery during detox and long-term rehabilitation.
- 18 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 74, 75172
Open AccessThe K-Hole Collapse: A Systematic Review of Multi-Organ Somatotoxicity and Management Strategies in Chronic Ketamine Misuse
Ketamine is a psychoactive substance and an N-methyl-D-aspartate (NMDA) receptor antagonist, commonly used in anesthesiology, psychiatry, and emergency medicine. Its unique dissociative properties have led to a significant global increase in recreational misuse, particularly among young adults in nightlife environments. While the medical applications of ketamine demonstrate a favorable safety profile, its uncontrolled, chronic consumption poses severe toxicological risks. The primary mechanism of action of ketamine relies on blocking NMDA receptors, which leads to a secondary glutamate surge and localized neurotoxicity. This study aims to systematically evaluate the multi-organ manifestations, clinical complications, and management strategies associated with ketamine misuse. The article was developed using the "PubMed" and "Google Scholar" databases, with a particular emphasis on articles published after 2021. Chronic recreational ketamine misuse induces severe somatotoxic and neuropsychiatric injuries, including permanent cognitive and executive deficits, ketamine-induced uropathy (KIU) with secondary hydronephrosis, and excruciating gastrointestinal episodes ("ketamine cramps") triggered by sphincter of Oddi dyskinesia. Recent reports also highlight significant structural cardiac remodeling, myocardial fibrosis, and the risk of hypercapnic respiratory failure during acute, high-dose intoxications. Multidisciplinary treatment requires absolute abstinence as the cornerstone of therapy, combined with targeted pharmacotherapy, symptomatic clinical stabilization, and psychotherapy. Due to a therapeutic gap resulting from the lack of established pharmacological treatments to reduce ketamine cravings, further clinical trials are essential to improve patient recovery during detox and long-term rehabilitation.
- Open Access
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74862
Combined Trochleoplasty, Tibial Tuberosity Transfer, and Medial Patellofemoral Ligament Reconstruction in Recurrent Patellar Instability: Indications, Surgical Strategy, and Outcomes – A Narrative Review
Background. Recurrent patellar instability is a multifactorial condition associated with trochlear dysplasia, abnormal extensor mechanism alignment, and medial patellofemoral ligament (MPFL) insufficiency. Isolated procedures may not address all anatomical abnormalities, leading to persistent instability. Therefore, combined procedures such as trochleoplasty, tibial tuberosity transfer (TTO), and MPFL reconstruction are increasingly used. Aim. To evaluate the evidence on indications, biomechanical rationale, and outcomes of combined trochleoplasty, TTO, and MPFL reconstruction in recurrent patellar instability. Material and methods. A narrative review of PubMed-indexed literature was conducted, including clinical studies, systematic reviews, and biomechanical analyses. Data were synthesized qualitatively due to heterogeneity in patient populations, surgical techniques, and outcomes. Results. Combined procedures are associated with low redislocation rates and generally favorable functional outcomes in selected patients. MPFL reconstruction restores medial soft-tissue restraint, TTO improves patellar tracking, and trochleoplasty enhances osseous containment in high-grade trochlear dysplasia. Combined approaches appear more reliable than isolated procedures in patients with multiple anatomical risk factors. However, functional outcomes and return to sport remain variable, influenced by cartilage status and chronicity of instability. Conclusions. Combined surgery is a logical and effective strategy for complex recurrent patellar instability when based on careful anatomical assessment. Success depends on appropriate patient selection rather than routine use. Further prospective studies are needed to refine indications and optimize surgical strategies.
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74862
Open AccessCombined Trochleoplasty, Tibial Tuberosity Transfer, and Medial Patellofemoral Ligament Reconstruction in Recurrent Patellar Instability: Indications, Surgical Strategy, and Outcomes – A Narrative Review
Background. Recurrent patellar instability is a multifactorial condition associated with trochlear dysplasia, abnormal extensor mechanism alignment, and medial patellofemoral ligament (MPFL) insufficiency. Isolated procedures may not address all anatomical abnormalities, leading to persistent instability. Therefore, combined procedures such as trochleoplasty, tibial tuberosity transfer (TTO), and MPFL reconstruction are increasingly used. Aim. To evaluate the evidence on indications, biomechanical rationale, and outcomes of combined trochleoplasty, TTO, and MPFL reconstruction in recurrent patellar instability. Material and methods. A narrative review of PubMed-indexed literature was conducted, including clinical studies, systematic reviews, and biomechanical analyses. Data were synthesized qualitatively due to heterogeneity in patient populations, surgical techniques, and outcomes. Results. Combined procedures are associated with low redislocation rates and generally favorable functional outcomes in selected patients. MPFL reconstruction restores medial soft-tissue restraint, TTO improves patellar tracking, and trochleoplasty enhances osseous containment in high-grade trochlear dysplasia. Combined approaches appear more reliable than isolated procedures in patients with multiple anatomical risk factors. However, functional outcomes and return to sport remain variable, influenced by cartilage status and chronicity of instability. Conclusions. Combined surgery is a logical and effective strategy for complex recurrent patellar instability when based on careful anatomical assessment. Success depends on appropriate patient selection rather than routine use. Further prospective studies are needed to refine indications and optimize surgical strategies.
- Open Access
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74961
Thyroid Dysfunction and Quality of Life in Patients on Lithium Therapy: A Narrative Review
Introduction. Lithium remains the gold standard in the treatment of bipolar disorder (BD); however, its narrow therapeutic index and effects on the thyroid gland pose a significant therapeutic challenge and require systematic monitoring for adverse effects. Aim of the study. To analyze the mechanisms of thyroid dysfunction induced by long-term lithium therapy and evaluate patient monitoring strategies to optimize treatment safety and quality of life (QoL). Material and methods. A structured narrative review of the medical literature published between 2021 and 2026. Results. Lithium inhibits iodine uptake and thyroid hormone release, most commonly causing hypothyroidism. Symptoms such as fatigue, weight changes, and cognitive impairment significantly affect daily functioning and may overlap with depressive episodes in BD, substantially reducing QoL. Conclusions. Appropriate monitoring, diagnostic evaluation, and timely intervention are essential for minimizing complications. Patient education and interdisciplinary collaboration between psychiatrists and endocrinologists are key to maintaining QoL during lithium therapy, underscoring the need to integrate thyroid monitoring into routine psychiatric and endocrinological care.
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74961
Open AccessThyroid Dysfunction and Quality of Life in Patients on Lithium Therapy: A Narrative Review
Introduction. Lithium remains the gold standard in the treatment of bipolar disorder (BD); however, its narrow therapeutic index and effects on the thyroid gland pose a significant therapeutic challenge and require systematic monitoring for adverse effects. Aim of the study. To analyze the mechanisms of thyroid dysfunction induced by long-term lithium therapy and evaluate patient monitoring strategies to optimize treatment safety and quality of life (QoL). Material and methods. A structured narrative review of the medical literature published between 2021 and 2026. Results. Lithium inhibits iodine uptake and thyroid hormone release, most commonly causing hypothyroidism. Symptoms such as fatigue, weight changes, and cognitive impairment significantly affect daily functioning and may overlap with depressive episodes in BD, substantially reducing QoL. Conclusions. Appropriate monitoring, diagnostic evaluation, and timely intervention are essential for minimizing complications. Patient education and interdisciplinary collaboration between psychiatrists and endocrinologists are key to maintaining QoL during lithium therapy, underscoring the need to integrate thyroid monitoring into routine psychiatric and endocrinological care.
- Open Access
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74863
Impact of Sedentary Behavior on Metabolic Health in Adults: A Narrative Review
Background. Sedentary behavior is an independent determinant of metabolic health. Prolonged sitting is associated with insulin resistance, dyslipidemia, obesity, metabolic syndrome, and type 2 diabetes, even in physically active individuals. Aim. To synthesize evidence on the impact of sedentary behavior on metabolic health in adults, including epidemiological associations, mechanisms, and intervention effects. Material and methods. A systematic narrative review was conducted using PubMed and reference screening. Studies evaluating sedentary behavior and metabolic outcomes in adults were included. Due to heterogeneity, findings were synthesized thematically. Results. Higher sedentary time was consistently associated with adverse metabolic profiles, particularly impaired glucose metabolism and increased diabetes risk. Experimental studies show that interrupting sitting improves glucose and insulin responses. Mechanistic evidence supports links with reduced muscle activity and insulin sensitivity. Evidence for lipid profile and obesity is less consistent, and long-term intervention data remain limited. Conclusions. Sedentary behavior is a modifiable risk factor for metabolic dysfunction. Reducing and interrupting sitting should complement physical activity. Further studies should use standardized measures and clinically relevant endpoints.
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74863
Open AccessImpact of Sedentary Behavior on Metabolic Health in Adults: A Narrative Review
Background. Sedentary behavior is an independent determinant of metabolic health. Prolonged sitting is associated with insulin resistance, dyslipidemia, obesity, metabolic syndrome, and type 2 diabetes, even in physically active individuals. Aim. To synthesize evidence on the impact of sedentary behavior on metabolic health in adults, including epidemiological associations, mechanisms, and intervention effects. Material and methods. A systematic narrative review was conducted using PubMed and reference screening. Studies evaluating sedentary behavior and metabolic outcomes in adults were included. Due to heterogeneity, findings were synthesized thematically. Results. Higher sedentary time was consistently associated with adverse metabolic profiles, particularly impaired glucose metabolism and increased diabetes risk. Experimental studies show that interrupting sitting improves glucose and insulin responses. Mechanistic evidence supports links with reduced muscle activity and insulin sensitivity. Evidence for lipid profile and obesity is less consistent, and long-term intervention data remain limited. Conclusions. Sedentary behavior is a modifiable risk factor for metabolic dysfunction. Reducing and interrupting sitting should complement physical activity. Further studies should use standardized measures and clinically relevant endpoints.
- Open Access
- 4 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73946
Pollen-Food Allergy Syndrome: Pathogenesis, Diagnosis, Management, and Implications for Athletic Populations — A Narrative Review
Background. Pollen-food allergy syndrome (PFAS) is an IgE-mediated hypersensitivity reaction caused by cross-reactivity between airborne pollen allergens and homologous proteins in plant-derived foods. Aim. To provide a structured overview of PFAS pathogenesis, allergen components, regional epidemiology, clinical spectrum, diagnosis and management, with emphasis on its relevance for sports medicine. Material and methods. Narrative review of 25 full-text articles (1987–2025): position papers, large cohorts, randomised trials and the 2024 AAAAI Delphi consensus. Results. PFAS affects 4.7–53.8% of pollen-allergic patients; anaphylaxis is reported in 1.7–8.9%. PR-10 sensitisation drives the birch–Rosaceae pattern, profilins underlie milder polyreactive phenotypes, nsLTP and GRP are linked to severe, cofactor-dependent reactions. Sublingual immunotherapy with recombinant Mal d 1 and omalizumab are the most promising therapies; pollen immunotherapy alone is not currently endorsed for PFAS. Exercise, NSAIDs and uncontrolled rhinitis amplify severity, with direct relevance for athletes. Conclusions. PFAS is a heterogeneous, prevalent and clinically meaningful condition. Personalised diagnostics, cofactor avoidance and emerging biologicals will shape future management, especially for outdoor athletes exposed to lengthening pollen seasons under climate change.
- 4 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73946
Open AccessPollen-Food Allergy Syndrome: Pathogenesis, Diagnosis, Management, and Implications for Athletic Populations — A Narrative Review
Background. Pollen-food allergy syndrome (PFAS) is an IgE-mediated hypersensitivity reaction caused by cross-reactivity between airborne pollen allergens and homologous proteins in plant-derived foods. Aim. To provide a structured overview of PFAS pathogenesis, allergen components, regional epidemiology, clinical spectrum, diagnosis and management, with emphasis on its relevance for sports medicine. Material and methods. Narrative review of 25 full-text articles (1987–2025): position papers, large cohorts, randomised trials and the 2024 AAAAI Delphi consensus. Results. PFAS affects 4.7–53.8% of pollen-allergic patients; anaphylaxis is reported in 1.7–8.9%. PR-10 sensitisation drives the birch–Rosaceae pattern, profilins underlie milder polyreactive phenotypes, nsLTP and GRP are linked to severe, cofactor-dependent reactions. Sublingual immunotherapy with recombinant Mal d 1 and omalizumab are the most promising therapies; pollen immunotherapy alone is not currently endorsed for PFAS. Exercise, NSAIDs and uncontrolled rhinitis amplify severity, with direct relevance for athletes. Conclusions. PFAS is a heterogeneous, prevalent and clinically meaningful condition. Personalised diagnostics, cofactor avoidance and emerging biologicals will shape future management, especially for outdoor athletes exposed to lengthening pollen seasons under climate change.
- Open Access
- 11 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58209
The Impact of Anesthetic Modality Selection on Surgical Outcomes in Trauma Management
The selection of anesthesia during surgical management of injuries is of paramount importance in ensuring patient comfort, procedural safety, and optimal surgical outcomes. The determination of the anesthetic modality is made by the anesthesiologist in consultation with the surgical team, taking into consideration the patient's medical status, the nature and extent of the injury, the anticipated duration of the procedure, and, when feasible, the patient’s preferences.
- 11 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58209
Open AccessThe Impact of Anesthetic Modality Selection on Surgical Outcomes in Trauma Management
The selection of anesthesia during surgical management of injuries is of paramount importance in ensuring patient comfort, procedural safety, and optimal surgical outcomes. The determination of the anesthetic modality is made by the anesthesiologist in consultation with the surgical team, taking into consideration the patient's medical status, the nature and extent of the injury, the anticipated duration of the procedure, and, when feasible, the patient’s preferences.
- Open Access
- 5 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 57768
Magnesium Homeostasis and Implications for Human Health: A Review of the Literature
Magnesium ions (Mg²⁺) is a vital ion for human health, involved in numerous bodily functions, including energy production and protein synthesis. Despite its significance, serum magnesium levels are often overlooked in clinical settings, even though they can be disrupted in various health conditions. This review delves into the role of magnesium in human health and disease, highlighting its importance in key organs like the brain, heart, and muscles. Magnesium supplementation has shown promise in treating conditions such as migraine, depression, heart disease, and asthma. Recent discoveries have unveiled genetic factors, including mutations in specific genes, that can lead to magnesium deficiency. Additionally, certain medications, such as diuretics and proton pump inhibitors, can contribute to low magnesium levels. This review explores the mechanisms of magnesium regulation in the intestines, kidneys, and bones.
- 5 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 57768
Open AccessMagnesium Homeostasis and Implications for Human Health: A Review of the Literature
Magnesium ions (Mg²⁺) is a vital ion for human health, involved in numerous bodily functions, including energy production and protein synthesis. Despite its significance, serum magnesium levels are often overlooked in clinical settings, even though they can be disrupted in various health conditions. This review delves into the role of magnesium in human health and disease, highlighting its importance in key organs like the brain, heart, and muscles. Magnesium supplementation has shown promise in treating conditions such as migraine, depression, heart disease, and asthma. Recent discoveries have unveiled genetic factors, including mutations in specific genes, that can lead to magnesium deficiency. Additionally, certain medications, such as diuretics and proton pump inhibitors, can contribute to low magnesium levels. This review explores the mechanisms of magnesium regulation in the intestines, kidneys, and bones.
- Open Access
- 1 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57735
Do Anabolic Androgenic Steroids Really Cause Harm? A Comprehensive Examination of Adverse Effects
Anabolic steroids, synthetic derivatives of testosterone, are frequently employed in clinical settings to address hormonal deficiencies and, controversially, in athletic contexts to augment physical performance. These compounds exert their physiological effects by activating androgen receptors, thereby stimulating protein synthesis, promoting muscle hypertrophy, and accelerating tissue regeneration. These processes are mediated through the modulation of insulin-like growth factor-1 (IGF-1) and the inhibition of glucocorticoid-induced catabolism. However, the unsupervised and excessive use of anabolic steroids, often motivated by the pursuit of rapid aesthetic or performance enhancement, is associated with a myriad of adverse health outcomes. Such complications encompass damage to the reproductive system, renal dysfunction, hepatotoxicity, cardiovascular pathology, and neuropsychiatric disturbances. Given their substantial potential for misuse, anabolic steroids are stringently regulated, necessitating that healthcare professionals remain astutely aware of their adverse effects to ensure timely recognition and intervention.
- 1 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57735
Open AccessDo Anabolic Androgenic Steroids Really Cause Harm? A Comprehensive Examination of Adverse Effects
Anabolic steroids, synthetic derivatives of testosterone, are frequently employed in clinical settings to address hormonal deficiencies and, controversially, in athletic contexts to augment physical performance. These compounds exert their physiological effects by activating androgen receptors, thereby stimulating protein synthesis, promoting muscle hypertrophy, and accelerating tissue regeneration. These processes are mediated through the modulation of insulin-like growth factor-1 (IGF-1) and the inhibition of glucocorticoid-induced catabolism. However, the unsupervised and excessive use of anabolic steroids, often motivated by the pursuit of rapid aesthetic or performance enhancement, is associated with a myriad of adverse health outcomes. Such complications encompass damage to the reproductive system, renal dysfunction, hepatotoxicity, cardiovascular pathology, and neuropsychiatric disturbances. Given their substantial potential for misuse, anabolic steroids are stringently regulated, necessitating that healthcare professionals remain astutely aware of their adverse effects to ensure timely recognition and intervention.
- Open Access
- 30 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 77, 56907
The Hormonal dysregulation and its consequences in Obese Women - overview
Introduction Obesity, a global health challenge, significantly impacts women's hormonal balance, affecting metabolic and reproductive health. Defined as a BMI >30 kg/m² by WHO, its prevalence is rising, creating substantial health and economic challenges. Aim of Study This study explores the effects of obesity on women's hormonal regulation, emphasizing associated conditions like PCOS, insulin resistance, infertility, and cardiometabolic diseases, while identifying mechanisms and potential interventions. Material and Methods A review of 34 peer-reviewed articles (2000–2024) using PRISMA criteria analyzed hormonal imbalances caused by obesity, focusing on adipokines such as leptin and adiponectin, and their roles in glucose metabolism, lipid regulation, and inflammation. Analysis of Literature Obesity-induced chronic inflammation disrupts insulin regulation, sex hormones, and the hypothalamic-pituitary-adrenal axis. It causes ovulatory disorders, reduced oocyte quality, and impaired endometrial receptivity. Mechanisms like insulin resistance, hyperandrogenism, and leptin dysfunction are central to these effects. Conclusion A multidimensional treatment approach, including lifestyle changes, pharmacotherapy (e.g., GLP-1 agonists), and surgical interventions, is essential. Personalized strategies can alleviate symptoms, improve metabolic and reproductive outcomes, and enhance quality of life for women with obesity.
- 30 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 77, 56907
Open AccessThe Hormonal dysregulation and its consequences in Obese Women - overview
Introduction Obesity, a global health challenge, significantly impacts women's hormonal balance, affecting metabolic and reproductive health. Defined as a BMI >30 kg/m² by WHO, its prevalence is rising, creating substantial health and economic challenges. Aim of Study This study explores the effects of obesity on women's hormonal regulation, emphasizing associated conditions like PCOS, insulin resistance, infertility, and cardiometabolic diseases, while identifying mechanisms and potential interventions. Material and Methods A review of 34 peer-reviewed articles (2000–2024) using PRISMA criteria analyzed hormonal imbalances caused by obesity, focusing on adipokines such as leptin and adiponectin, and their roles in glucose metabolism, lipid regulation, and inflammation. Analysis of Literature Obesity-induced chronic inflammation disrupts insulin regulation, sex hormones, and the hypothalamic-pituitary-adrenal axis. It causes ovulatory disorders, reduced oocyte quality, and impaired endometrial receptivity. Mechanisms like insulin resistance, hyperandrogenism, and leptin dysfunction are central to these effects. Conclusion A multidimensional treatment approach, including lifestyle changes, pharmacotherapy (e.g., GLP-1 agonists), and surgical interventions, is essential. Personalized strategies can alleviate symptoms, improve metabolic and reproductive outcomes, and enhance quality of life for women with obesity.